Premium
Pregabalin‐associated rhabdomyolysis
Author(s) -
Gunathilake Roshan,
Boyce Laura E,
Knight Anne T
Publication year - 2013
Publication title -
medical journal of australia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 131
eISSN - 1326-5377
pISSN - 0025-729X
DOI - 10.5694/mja13.10769
Subject(s) - referral , knight , medicine , library science , general hospital , family medicine , psychology , computer science , physics , astronomy
Pregabalin is a γ-aminobutyric acid (GABA) analogue that binds to the a2-d subunit of voltage-gated calcium channels in the central nervous system. It is approved for treating neuropathic pain and partial epilepsy. Pregabalin was listed on the Pharmaceutical Benefits Scheme in March 2013 as Australia’s first drug to be subsidised specifically for neuropathic pain